Sigma Planning Corp’s CollPlant Biotechnologies CLGN Stock Holding History

Sigma Planning Corp’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,070	Closed	-$214K	–	1387
2021 Q4	$214K	Sell	13,070 -5,565	-30%	-$99.3K	0.01%	1250
2021 Q3	$315K	Buy	+18,635	New	+$335K	0.01%	1036
2021 Q2	–	Sell	-19,700	Closed	-$265K	–	1429
2021 Q1	$265K	Buy	+19,700	New	+$297K	0.01%	1058

Other funds holding CLGN

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

IMOV

Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BFEC

Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sigma Planning Corp's CLGN Position: Q1 2022 in Review

Sigma Planning Corp sold out of CollPlant Biotechnologies (CLGN) in Q1 2022, closing a stake of 13,070 shares — an estimated $214K sold.

Sigma Planning Corp first reported a position in CLGN in Q1 2021 and held it in 3 quarters. The position peaked at $315K in Q3 2021. 16 funds tracked by Wall St. Rank hold CLGN as of Q1 2022.

Sigma Planning Corp reported no remaining CollPlant Biotechnologies position as of Q1 2022 after selling out during the quarter.
Sigma Planning Corp sold 13,070 CollPlant Biotechnologies shares in Q1 2022, an estimated $214K.
Sigma Planning Corp first reported a position in CollPlant Biotechnologies in Q1 2021 and held it in 3 quarters.
Sigma Planning Corp's CollPlant Biotechnologies position peaked at $315K in Q3 2021.
16 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2022.

Based on Sigma Planning Corp's 13F filing for Q1 2022, filed 20 Apr 2022.